IUIS -Pasteur Network Immuno Cambodia 2025: Immune responses to arboviruses from a one health perspective, SIem Reap, Cambodia, November 24-29. This 6-day course will provide an in-depth exploration of the […]
On April 4th, Institut Pasteur du Cambodge conducted the final dissemination meeting of the DENTHOM study (Study of dengue-like illness in Kampong Thom Province, Cambodia). The aim of the study was to […]
Interview with Dr. Paul Alain Tagnouokam Ngoupo, Research Scientist, Head of the Immunology Platform, Centre Pasteur du Cameroun January 2025 Dr. Tagnouokam Ngoupo, tell us about your background. How did […]
On December 17th 2024, the Centre Pasteur du Cameroun (CPC) organized the 1st Day of the Young Scientist Community (1ère journée la Communauté Jeune Scientifique) during which CPC doctoral students […]
On December 12th, PICREID collaborator Dr. Tineke CANTAERT gave a talk at the International Virtual Seminars on Arbovirus Biology entitled “Immune responses in asymptomatic dengue-infected cases reveal immune signatures correlated to protection […]
From December 3 to 6, 2024, Dr. Janin Nouhin, Deputy Head of the Virology Unit at Institut Pasteur du Cambodge (IPC), represented IPC at the 20th International Congress on Infectious […]
October 2024 PICREID investigators from the Centre Pasteur du Cameroun and the Institut Pasteur du Cambodge are in Japan for training in sero-neutralization techniques at Hokkaido University – International Joint […]
October 17th, 2024 PICREID collaborator Dr. Tineke Cantaert, Head of the Immunology Unit at Institut Pasteur du Cambodge, was a featured speaker in the LABEX IBEID Conference “Adapting to Change: […]
December 2023 Dr. Fall, could you tell us about your background? I am currently a research associate at the Institut Pasteur de Dakar (IPD) in Senegal, where my research focuses […]
The Centers for Research in Emerging Infectious Diseases (CREID) Network has launched the 4th round of the Call for Applications for the CREID Pilot Research Program. Eligibility and Fit The […]
July 2023 Dr. Mohamed Ali, tell us a bit about your background. My name is Souand Mohamed Ali, and I am currently a postdoctoral fellow at Institut Pasteur de Paris […]
PICREID Principal Investigator Professor Anavaj Sakuntabhai was included in the magazine Le Point’s 2023 Palmares of “100 inventions that will change our lives!” His work on the development of a […]
March 2023 Sokchea, what is your background, and how did you end up working at Institut Pasteur du Camboge? My name is Sokchea Lay, and I am from Cambodia. I […]
The PICREID team, with generous support from the Virology and Global Health Departments of the Institut Pasteur as well as the Fondation Pasteur Japon, is pleased to welcome three expert […]
The PICREID midterm meeting will take place at Institut Pasteur on January 19th-20th, 2023. The final meeting agenda is under development, but the overall program is as follows: Day 1: […]
November 25th, 2022 As we come up on the halfway point of the project, our Program Directors / Principal Investigators answer questions on the unique research being carried out in […]
Dr. Etienne Simon Lorière joins Professor Anavaj Sakuntabhai as Program Director / Principal Investigator of PICREID (in NIH terms, this is called “mPD/PIs” for “Multiple PD/PIs”). Prof. Sakuntabhai and Dr. […]
The CREID network has published a 3rd call for proposals as part of its Pilot Program to support, train and mentor the next generation of emerging infectious disease researchers. This […]
The PICREID team is pleased to welcome Dr. Nazif Elaldi of Sivas Cumhuriyet University to the PICREID consortium. A new collaboration has been initiated to study Crimean Congo Hemorrhagic Fever […]
PICREID researchers in Institut Pasteur du Cambodge and Institut Pasteur Paris have received additional funding from the NIH to research tick-borne diseases in Cambodia. More information in “Research Studies.”
Necessary cookies are always active. Optional categories stay blocked until you allow them.
Your browser privacy signal is active, so analytics and marketing remain disabled.